Search

everythinglearnresearchcommunity

for

Search:↓

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Many medications may be linked to cognitive disorders, but most lack warnings on labels.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Using electronic health records can help identify drug side effects but has some limitations.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Platelet-rich plasma is a promising and cost-effective treatment for hair and skin issues in older adults in India.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Baricitinib is effective and safe for treating severe alopecia areata.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Baricitinib is an effective treatment for severe alopecia areata.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Pharmacy care clinics can reduce some emergency visits by managing certain conditions and medication issues.

Pharmacists play a key role in managing the use of anxiety medications and ensuring patients use them correctly.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The Drug Ontology was updated to better classify drugs for hypertension, malaria, and opioid abuse, and to allow for more accurate research queries.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Topical 3% minoxidil effectively and safely enhances facial hair in transgender men.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Perifollicular elastolysis is poorly understood, with limited treatment options and inconsistent results.